GSDME and cancer: However, in some cancer cells, the promoter region of GSDME is in a state of low expression owing to abnormal hypermethylation, and caspase-3 activated by anticancer drugs cleaves the downstream apoptotic protein poly (ADP-ribose) polymerase (PARP) instead of GSDME, thereby initiating apoptosis.